C71T
CANCELLED SECTION 71
05/08/2026
Back to search
Official data from USPTO
LB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/02/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
09/26/2018
Registration date
10/22/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/08/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
US
Examiner
HUSSAIN, TASNEEM
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letters "LB" in lowercase segmented lettering combined together to form an incomplete helix symbol.
Holders and representatives
Holders
Legend Biotech USA Inc.
NANJING LEGEND BIOTECH CO., LTD.
Representatives
Preetha Chakrabarti Crowell & Moring LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating multiple myelomablood cancer and solid tumor; chemico-pharmaceutical preparations for treating multiple myelomablood cancer and solid tumor; drugs for medical purposes for treating multiple myelomablood cancer and solid tumor; serotherapeutic medicines; biological preparations for medical purposes for treating multiple myelomablood cancer and solid tumor; chemical preparations for pharmaceutical purposes for treating multiple myelomablood cancer and solid tumor; stem cells for medical purposes; biological tissue cultures for medical purposes; biochemical drug for treating multiple myelomablood cancer and solid tumor; blood productsblood plasma
Class 42
Technical research in the field of pharmaceutical studies; consulting services for others in the field of designplanningimplementation project management of scientific research; research and development of new products for others; scientific laboratory services; chemical analysis; chemistry consultation; chemical research; bacteriological research; biological research
Class 44
Medical clinic services; medical assistance; telemedicine services; medicalphysical rehabilitation and physical therapy services; preparation of prescriptions by pharmacists; hospital services; health care; medical and pharmaceutical consultation; nursingmedical; veterinary services
Publications
History of USPTO decisions and trademark events.
32 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/22/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
04/20/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/15/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/15/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/15/2024
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
03/07/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/14/2020
FIMP
FINAL DISPOSITION PROCESSED
02/14/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/22/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2019
PUBO
PUBLISHED FOR OPPOSITION
08/06/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2019
ALIE
ASSIGNED TO LIE
07/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/20/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2019
RFNT
REFUSAL PROCESSED BY IB
05/18/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/30/2019
RFRR
REFUSAL PROCESSED BY MPU
04/30/2019
MAFR
APPLICATION FILING RECEIPT MAILED
04/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/05/2019
CNRT
NON-FINAL ACTION WRITTEN
04/04/2019
DOCK
ASSIGNED TO EXAMINER
04/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/02/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/27/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/21/2019
Continuous trademark protection
Get notified about every new filing that threatens LB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.